Berkeley Lovelace Jr. is a health and medical reporter for NBC News. He covers the Food and Drug Administration, with a special focus on Covid vaccines, prescription drug pricing and health care. He ...

The Indianapolis pharma giant announced it will acquire Orna Therapeutics for $2.4 billion, putting Lily in the rat race to develop injectable, in vivo CAR-T therapies to eliminate the costly cell ...

In a sudden reversal, the U.S. Food and Drug Administration (FDA) has agreed to review Moderna’s experimental mRNA influenza vaccine.

The CDC revised the guidance for immunizations, which one attorney general described as "scientifically unsound" and ...

Researchers summarize key insights from the world’s first comprehensive investigation into how a pandemic started.

Updated 2024-2025 COVID-19 vaccines significantly reduced the risk for hospitalization and severe outcomes despite the emergence of new viral lineages.

In a sudden reversal, the US Food and Drug Administration has agreed to review Moderna’s experimental mRNA influenza vaccine.

The move might at first sound like little more than a reduced hassle—and maybe reckless, since there was good evidence in ...

Foreign substances such as mold, hair, and silicon dioxide (silica) were found in COVID-19 vaccines, potentially introduced ...

A 2023 law championed by Republicans requires the CDC have a director confirmed by the Senate. For months, though, it’s had ...

Researchers suggest a vaccine could replace multiple jabs every year for seasonal respiratory infections and be on hand in the event of a new pandemic.